hamburger-icon
close-icon

invest-iconInvest

trade-iconTrade

depository-iconInsurance

watch-iconPMS

depository-iconTrading Platforms

depository-iconDepository

watch-iconWatch Markets

depository-iconFPI

watch-iconMerchant Banking

watch-iconInstitutional Broking

watch-iconMTF

partner-iconBecome a Partner

partner-iconKnowledge Center

watch-iconResearch

about-iconAbout Us

support-iconSupport

support-iconPricing

support-iconQuick Links

support-iconBlog

hamburger-icon
close-icon

Mukka Proteins Ltd

  • BSE Code : 544135
  • NSE Symbol : MUKKA
  • ISIN : INE0CG401037
  • Industry :FOOD - PROCESSING - INDIAN
Trade Now

up-arrow 34.90 -0.15(-0.43%)

Open Price (₹)

35.05

Prev. Close (₹)

35.05

Volume (No’s)

700,088

Market Cap (₹)

1,047.00

Low Price (₹)

34.80

High Price (₹)

35.30

 

Book Closure

From Date To Date Announcement
14-May-2024 NA Mukka Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2024 inter alia to consider and approve We wish to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Tuesday 14th May 2024 inter alia to consider and approve the audited financial results (standalone and consolidated) of the Company for the quarter and year ended 31st March 2024. Audited financial results for the quarter and year ended 31st March 2024. (As Per BSE Announcement Dated on 14.05.2024)
28-Mar-2024 NA Mukka Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/03/2024 inter alia to consider and approve the unaudited financial results (standalone and consolidated) of the Company for the quarter and nine months period ended 31st December 2023. Intimation of unaudited financial results for the quarter ended 31st December 2023 Intimation of unaudited financial results for the quarter and nine months ended 31st December 2023 (As per BSE Announcement Dated on 28/03/2024)
07-Mar-2024 NA Sub: Listing of Equity Shares of Mukka Proteins Limited (IPO) In pursuance of Regulation 3.1.1 of the National Stock Exchange (Capital Market) Trading Regulations Part A, it is hereby notified that the list of securities further admitted to dealings on the National Stock Exchange (Capital Market segment) with effect from March 07, 2024 and the designated security codes thereof shall be as specified in Annexure. In pursuance of Regulation 2.5.5 of the National Stock Exchange (Capital Market) Trading Regulations Part A, it is hereby notified that the respective lot sizes in respect of securities above shall be as specified in Annexure. For the purpose of trading on the system, the security shall be identified only by its designated codes and trading in such securities shall be in such lot sizes as specified in Annexure. Members are requested to note that the above security will be part of pre-open session for IPO and Other category of scrips as per SEBI circular no. CIR/MRD/DP/01/2012 & CIR/MRD/DP/02/2012 dated January 20, 2012. This circular shall be effective from March 07, 2024. For and on behalf of National Stock Exchange of India Limited Symbol MUKKA Name of the Company Mukka Proteins Limited Series BE* ISIN INE0CG401037 Face Value Re. 1/- Paid-up Value Re. 1/- Issue Price for the current public issue Rs. 28/- per share Security Description Equity shares of Re. 1/- each fully paid up No. of securities 300000000 Distinctive number range As per Annexure I Market lot 1 Pari Passu Yes Lock in details As per Annexure I *Note: Currently the securities shall be available for trading in Series 'BE' and subsequently be shifted to Series 'EQ' as per SEBI circular no. CIR/MRD/DP/01/2012 & CIR/MRD/DP/02/2012 dated January 20, 2012 Address of Registered Office of the Company: Mukka Proteins Limited Mukka Corporate House, Door, Mukka Corporate House, Door, No. 18-2-16/4, First Cross, NG Road, Attavara, Dakshina, Kannada, Mangaluru -575001, Karnataka, India. Tel: +918244252889 E-mail: cs@mukkaproteins.com Website: www.cameoindia.com Company Secretary: Mehaboobsab Chalyal Web Site: www.mukkaproteins.com Email id: cs@mukkaproteins.com Financial Year: April 01 - March 31 Address of Registrar: Cameo Corporate Services Limited Subramanian Building, 5th Floor, No. 1 Club House Road, Chennai - 600 002, India Tel: +91 4440020700 (5 lines) Fax: +91 4428460129 Email: priya@cameoindia.com Website: www.cameoindia.com Contact Person: K Sreepriya
07-Mar-2024 NA Trading Members of the Exchange are hereby informed that effective from Thursday, March 7, 2024, the equity shares of Mukka Proteins Limited shall be listed and admitted to dealings on the Exchange in the list of 'T ' Group of Securities. Further in terms of SEBI circular No. CIR/MRD/DP/02/2012 dated January 20, 2012; the scrip will be in Trade-for-Trade segment for 10 trading days. Name of the company Mukka Proteins Limited Registered Office: Address: Mukka Corporate HouseDoor No 18-2 -16/4 First Cross N G Road Attavara Dakshina Kannada 575001 Tel :0824 - 4252889 Email: cs@mukkaproteins.com Website : www.mukkaproteins.com No. of Securities 300000000 Equity Shares Of Rs.1/- each fully paid up Distinctive Number range 1 To 300000000 Scrip ID on BOLT System MUKKA Abbreviated Name on BOLT System MUKKA Scrip Code 544135 ISIN No. INE0CG401037 Market Lot 1 Issue Price for the current Public issue Rs. 28/- per share (Face Value of Rs. 1/- and premium of Rs. 27/-) Date of Allotment in the public issue: March 6, 2024 Pari Pasu Yes Financial Year Mar-31 Lock in detail As per Annexure I Shareholding Pattern As per Annexure II a)Trading Members may note that as per the guidelines issued by SEBI dated 16th February, 2000, securities of the company will only be traded in Dematerialised form. b) Further the trading members may please note that the above mentioned scrip will be a part of Special Pre-open Session (SPOS) on Thursday, March 7, 2024 . For further information on SPOS, the trading members are requested to refer to the Exchanges notice no. 20120216-29 dated February 16, 2012 on Enabling Special Pre-open Session for IPOs & Relisted Scrips. c) The company has informed the Exchange that in respect of shares in demat form, necessary corporate action has been executed to have the lock-in period marked in the depository records. d) The Registrar to the issue as mentioned in the prospectus is given below Cameo Corporate Services Limited Subramanian Building, 5th Floor, No. 1 Club House Road, Chennai - 600 002, India Tel: +91 4440020700 (5 lines) Fax: +91 4428460129 Email: priya@cameoindia.com Investor Grievance Email: mukka@cameoindia.com Website: www.cameoindia.com Contact Person: K Sreepriya SEBI Registration Number: INR000003753
NA NA In continuation to the Exchange's notice no. 20240306-63 dated March 06, 2024, Trading Members are hereby informed that the trading in the equity shares of Mukka Proteins Limited (Scrip Code: 544135) shall be transferred from Trade for Trade segment (T Group) to Rolling segment with effect from Friday, March 22, 2024. Accordingly, the dealings in the equity shares of the company will be shifted under B Group. Trading Members may please contact Mr. Prasad Bhide on Tel. No. 022 - 2272 8388 for further details.

NIFTY:22,403.85  Up arrow
203.30(0.92%)
SENSEX:72,987.03  Up arrow
676.69(0.93%)

Product

Trading


Useful links

Who we are

Connect with us

Stay on top of the markets with our bite-sized newsletter delivered right to your Inbox!

footer-arrow-icon
appstore appstore

#1011 Solitaire Corporate Park, Andheri Ghatkopar Link Road, Chakala, Andheri (E), Mumbai - 400093.

Arihant Capital Markets Limited is a SEBI registered stock broker and depository participant. SEBI Registration number for NSE & BSE :- INZ000180939; NSDL - IN-DP-127-2015 DP ID-IN301983; CDSL DP ID-43000;NCDEX - 01274; MCX - 56565; AMFI - ARN 15114; SEBI Merchant Banking Reg. No. - MB INM000011070; SEBI Research Analyst Reg. No. - INH000002764. Registered Address: 6, Lad colony, Y.N. Road, Indore – 452001.Corporate office address: #1011 Solitaire Corporate Park, Andheri Ghatkopar Link Road, Chakala, Andheri (E), Mumbai - 400093.

Please carefully read the risk disclosure document as prescribed by SEBI, as well as the 'Do’s and Don’ts' provided by NSE, BSE, NCDEX, and MCX. If you have any complaints related to securities broking, kindly contact us at complaint@arihantcapital.com. For DP-related matters, please reach out to us at depository@arihantcapital.com.

If you want to register your complaints through SEBI Score Portal please click here. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances

Investments in securities market are subject to market risks; read all the related documents carefully before investing.

Disclaimer: Arihant Capital Markets Limited is engaged in client based and proprietary trading on various exchanges.

  • ATTENTION INVESTORS :
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • For Stock Broking Transaction 'Prevent unauthorised transactions in your account - update your mobile numbers/email IDs with your stockbrokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day.
  • For Depository Transaction 'Prevent Unauthorized Transactions in your demat account - Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL/NSDL on the same day.
  • If you are subscribing to an IPO, there is no need to issue cheques. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
  • Investors should be cautious on unsolicited emails and SMS advising to buy, sell or hold securities and trade only on the basis of informed decision. Investors are advised to invest after conducting appropriate analysis of respective companies and not to blindly follow unfounded rumours, tips etc. Further, you are also requested to share your knowledge or evidence of systemic wrongdoing, potential frauds or unethical behaviour through the anonymous portal facility provided on BSE & NSE website.
  • Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Awareness regarding guidelines of margin collection:
1)Stock brokers can accept securities as margins from clients only by way of pledge in the depository system w.e.f September 01, 2020.
2)Update your e-mail and phone number with your stock broker / depository participant and receive OTP directly from depository on your e-mail and/or mobile number to create pledge.
3)Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month.
Issued in the interest of investors

Dear Investor - As you are aware, under the rapidly evolving dynamics of financial markets, it is crucial for investors to remain updated and well-informed about various aspects of investing in securities market. In this connection, please find a link to the BSE Investor Protection Fund website where you will find some useful educative material in the form of text and videos, so as to become an informed investor. https://www.bseipf.com/investors_education.html

Copyright © 2019 Arihant Capital Markets Ltd. All rights Reserved.

Designed,Developed and Content powered by CMOTS Infotech (ISO 9001:2015 certified)